Evidence map›Paper›PMID 30600616›Full record

ArticleWorld psychiatry : official journal of the World Psychiatric Association (WPA)2019

Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.

Geoffrey M Reed, Michael B First, Cary S Kogan, Steven E Hyman, Oye Gureje, Wolfgang Gaebel, Mario Maj, Dan J Stein, Andreas Maercker, Peter Tyrer and 31 more

Registry-linked trialAbstract read
In one paragraph

Article in World psychiatry : official journal of the World Psychiatric Association (WPA), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05130853 (Social Cognition Individualized Activities Lab), which is not on this map. Cited by 245 papers, 20 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 20 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05130853 nacompletednot on this mapstarted 2021, after this paper: background citation

Social Cognition Individualized Activities Lab (SoCIAL) for the Training of Social Cognition and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-life Functioning

TypeinterventionalSponsorUniversity of Campania Luigi VanvitelliRan2021 to 2022Enrolled48ConditionsSchizophrenia, Schizo Affective DisorderArmsSocial Skills and Neurocognitive Individualized Training (SoCIAL), Treatmment-as-usual
3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 20 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Geoffrey M ReedDepartment of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Michael B FirstDepartment of Psychiatry, Columbia University Medical Center, New York, NY, USA.
Cary S KoganSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.
Steven E HymanStanley Center for Psychiatric Research, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Oye GurejeDepartment of Psychiatry, University of Ibadan, Ibadan, Nigeria.
Wolfgang GaebelDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Mario MajDepartment of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.
Dan J SteinDepartment of Psychiatry, University of Cape Town, and South African Medical Research Council Unit on Risk and Resilience in Mental Disorders, Cape Town, South Africa.
Andreas MaerckerDepartment of Psychology, University of Zurich, Zurich, Switzerland.
Peter TyrerCentre for Mental Health, Imperial College, London, UK.
Angelica ClaudinoDepartment of Psychiatry, Universidade Federal de São Paulo (UNIFESP/EPM), São Paulo, Brazil.
Elena GarraldaCentre for Mental Health, Imperial College, London, UK.
Luis Salvador-CarullaResearch School of Population Health, Australian National University, Canberra, ACT, Australia.
Rajat RayNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
John B SaundersCentre for Youth Substance Abuse Research, University of Queensland, Brisbane, QLD, Australia.
Tarun DuaDepartment of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Vladimir PoznyakDepartment of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
María Elena Medina-MoraNational Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
Kathleen M PikeDepartment of Psychiatry, Columbia University Medical Center, New York, NY, USA.
José L Ayuso-MateosDepartment of Psychiatry, Universidad Autonoma de Madrid; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.
Shigenobu KanbaDepartment of Neuropsychiatry, Kyushu University, Fukuoka, Japan.
Jared W KeeleyDepartment of Psychology, Virginia Commonwealth University, Richmond, VA, USA.
Brigitte KhouryDepartment of Psychiatry, American University of Beirut Medical Center, Beirut, Lebanon.
Valery N KrasnovMoscow Research Institute of Psychiatry, National Medical Research Centre for Psychiatry and Narcology, Moscow, Russian Federation.
Maya KulyginaMoscow Research Institute of Psychiatry, National Medical Research Centre for Psychiatry and Narcology, Moscow, Russian Federation.
Anne M LovellInstitut National de la Santé et de la Recherche Médicale U988, Paris, France.
Jair de Jesus MariDepartment of Psychiatry, Universidade Federal de São Paulo (UNIFESP/EPM), São Paulo, Brazil.
Toshimasa MarutaHealth Management Center, Seitoku University, Matsudo, Japan.
Chihiro MatsumotoJapanese Society of Psychiatry and Neurology, Tokyo, Japan.
Tahilia J RebelloDepartment of Psychiatry, Columbia University Medical Center, New York, NY, USA.
Michael C RobertsOffice of Graduate Studies and Clinical Child Psychology Program, University of Kansas, Lawrence, KS, USA.
Rebeca RoblesNational Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
Pratap SharanDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
Min ZhaoShanghai Mental Health Center and Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Assen JablenskyCentre for Clinical Research in Neuropsychiatry, University of Western Australia, Perth, WA, Australia.
Pichet UdomratnDepartment of Psychiatry, Prince of Songkla University, Hat Yai, Thailand.
Afarin Rahimi-MovagharIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Per-Anders RydeliusDepartment of Child and Adolescent Psychiatry, Karolinska Institute, Stockholm, Sweden.
Sabine Bährer-KohlerInternational Federation of Social Workers, Basel, Switzerland.
Ann D WattsEntabeni Hospital, Durban, South Africa.
Shekhar SaxenaHarvard T.H. Chan School of Public Health, Boston, MA, USA.

Funding

Department of Health 07/01/26World Health Organization 001
6 · The paper itself

Abstract

Following approval of the ICD-11 by the World Health Assembly in May 2019, World Health Organization (WHO) member states will transition from the ICD-10 to the ICD-11, with reporting of health statistics based on the new system to begin on January 1, 2022. The WHO Department of Mental Health and Substance Abuse will publish Clinical Descriptions and Diagnostic Guidelines (CDDG) for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders following ICD-11's approval. The development of the ICD-11 CDDG over the past decade, based on the principles of clinical utility and global applicability, has been the most broadly international, multilingual, multidisciplinary and participative revision process ever implemented for a classification of mental disorders. Innovations in the ICD-11 include the provision of consistent and systematically characterized information, the adoption of a lifespan approach, and culture-related guidance for each disorder. Dimensional approaches have been incorporated into the classification, particularly for personality disorders and primary psychotic disorders, in ways that are consistent with current evidence, are more compatible with recovery-based approaches, eliminate artificial comorbidity, and more effectively capture changes over time. Here we describe major changes to the structure of the ICD-11 classification of mental disorders as compared to the ICD-10, and the development of two new ICD-11 chapters relevant to mental health practice. We illustrate a set of new categories that have been added to the ICD-11 and present the rationale for their inclusion. Finally, we provide a description of the important changes that have been made in each ICD-11 disorder grouping. This information is intended to be useful for both clinicians and researchers in orienting themselves to the ICD-11 and in preparing for implementation in their own professional contexts.

Indexed as

clinical utilityculture-related guidancediagnosisdimensional approachesICD-11International Classification of Diseasesmental disorders

Identifiers

PMID30600616
PMCPMC6313247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.